Rare gene mutation links schizophrenia, autism and wellness in one island family

A study of Portuguese island families found that one ultra-rare CHD2 mutation can show up as schizophrenia in some carriers, autism in another, and no illness at all in a grandmother. The findings, published in Genomic Psychiatry, highlight how rare inherited variants can blur psychiatric boundaries and may point to shared biological pathways across diagnoses.

Why it matters: - The study suggests a single inherited mutation can produce different psychiatric outcomes inside the same family. - The findings challenge rigid diagnostic boundaries between schizophrenia, bipolar disorder, autism and intellectual disability. - Rare family-based studies can reveal genetic effects that large population studies may miss. - The work could help guide future treatments toward shared biological pathways rather than disorder-specific boxes.

What happened: - Researchers analyzed 173 multiplex families from the Portuguese island population of the Azores and Madeira. - The population traces to settlers who arrived about 600 years ago and remained relatively isolated. - The team found that 49 families, or just over 28%, included both psychosis and mood disorder in the same pedigree. - The study also found 12 families, or about 7%, with autism and intellectual disability alongside schizophrenia or mood disorder. - In one three-generation family, whole-genome sequencing identified an ultra-rare stop-gain mutation in CHD2. - The mutation appeared as schizophrenia in most carriers, as autism with intellectual disability in one sibling, and as no illness in the grandmother who carried it.

The details: - CHD2 helps organize chromatin architecture during brain development. - The gene is strongly linked to autism risk and is also discussed in childhood epilepsy. - The mutation was absent from two large schizophrenia and bipolar disorder reference databases. - The same variant appeared only once in more than 800,000 unrelated people in a global genomic catalog. - Sequenced relatives in the second and third generations who carried the variant had schizophrenia. - The father of one affected grandson was an obligate carrier and had schizophrenia, though he was not sequenced. - The study was based on the Portuguese Island Collection, a resource followed across four generations since the 1990s. - Autism was originally an exclusion criterion for the collection, so the autism count likely underestimates the true number in these families.

Between the lines: - The family data show that the same mutation can be necessary in one person and absent in another person with similar symptoms. - The study also leaves room for a phenocopy, meaning a case that looks inherited but may not share the same genetic cause. - The grandmother who carried the mutation without illness fits a pattern seen in prior research on older people with pathogenic variants who never develop the expected disease. - The result points to genetic risk as layered and incomplete, not deterministic. - An editorial in Genomic Psychiatry said the study meets large consortium research in the middle: top-down studies have shown shared genetics across diagnoses, while this family study shows the same pattern from the bottom up.

What's next: - The authors say the molecular effects of the CHD2 truncation remain speculative until tested in living cells. - The team notes that one sequenced relative failed quality control, leaving that inheritance path unresolved. - The pedigree size and how families were enrolled may affect the numbers. - Future studies will need to test whether rare variants like CHD2 converge on common biological pathways across psychiatric disorders. - The peer-reviewed paper is available open access at the full study. - The accompanying editorial is available open access at the editorial.

The bottom line: - One broken gene did not map to one diagnosis. In this family, it mapped to schizophrenia, autism and health, underscoring how much psychiatry still has to learn from rare inheritance.